Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo

INTRODUCTION: Bone metastasis remains incurable with treatment restricted to palliative care. Cabozantinib (CBZ) is targeted against multiple receptor tyrosine kinases involved in tumour pathobiology, including hepatocyte growth factor receptor (MET) and vascular endothelial growth factor receptor 2...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bone
Autores principales: Haider, Marie-Therese, Hunter, Keith D., Robinson, Simon P., Graham, Timothy J., Corey, Eva, Dear, T. Neil, Hughes, Russell, Brown, Nicola J., Holen, Ingunn
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier Science 2015
Materias:
Original Full Length Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768060/
https://ncbi.nlm.nih.gov/pubmed/26279137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2015.08.003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares